Suppr超能文献

p38丝裂原活化蛋白激酶的特异性抑制剂SB203580对佛波酯诱导的基质金属蛋白酶及其组织抑制剂调控的影响

Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.

作者信息

Park Myung-Jin, Park In-Chul, Hur Jin-Heang, Kim Mi-Suk, Lee Hyung-Chan, Woo Sang-Hyeok, Lee Kyung-Hee, Rhee Chang-Hun, Hong Seok-Il, Lee Seung-Hoon

机构信息

Laboratory of Cell Biology, Korea Cancer Center Hospital, Seoul.

出版信息

J Neurosurg. 2002 Jul;97(1):112-8. doi: 10.3171/jns.2002.97.1.0112.

Abstract

OBJECT

Expression of matrix metalloproteinases (MMPs) has been postulated to play a central role in brain tumor invasion; however, its underlying mechanism is not yet fully understood. In the present study, by assessing the effect of a specific p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, on the secretion of MMPs and in vitro invasion of various glioma cells, the authors attempt to define the role of the p38 MAPK pathway in the regulation of MMPs and tissue inhibitors of metalloproteinases (TIMPs) activated by phorbol ester (phorbol-12-myristate-13-acetate [PMA]) in the D54 human glioblastoma cell line.

METHODS

The activation of MAPKs was determined using Western blot analysis after addition of phospho-specific antibodies against these kinases, the status of MMPs and TIMPs was analyzed using gelatin zymography and Western blot analysis, and the invasion rate of D54 cells and other glioma cells was analyzed using a modified Boyden chamber assay. Treatment of D54 cells with PMA activated two distinct MAPKs, extracellular signal-regulated kinase (ERK) 1/2 and p38 MAPK, but not c-Jun N-terminal kinase/stress-activated protein kinase. Induction of MMP-9 production and MMP-2 activation by PMA were blocked by SB203580, a specific inhibitor of p38 MAPK, but not by PD98059, a specific inhibitor of ERK 1/2. In addition, PMA-induced downregulation of TIMP-1 and TIMP-2 secretion and upregulation of the membrane type I MMP, a major activator of MMP-2 on the cell surface, were reversed by SB203580 in these cells; the PMA-induced increase of invasion in vitro decreased when SB203580 was added to the top compartment of a modified Boyden chamber; and the inhibitor also reduced the MMP secretion and PMA-induced in vitro invasion in various glioma cell lines.

CONCLUSIONS

These results indicate that activation of p38 MAPK by PMA plays a central role in the regulation of MMPs and TIMPs in D54 cells, which has a major influence in tumor invasion and metastasis. Furthermore, inhibition of p38 MAPK by SB203580 blocked the secretion of MMPs and in vitro invasion of various glioma cells, underscoring a possible role of p38 MAPK inhibitors as antiinvasive and/or antimetastatic agents of malignant gliomas.

摘要

目的

基质金属蛋白酶(MMPs)的表达被认为在脑肿瘤侵袭中起核心作用;然而,其潜在机制尚未完全明确。在本研究中,通过评估特异性p38丝裂原活化蛋白激酶(MAPK)抑制剂SB203580对MMPs分泌及各种胶质瘤细胞体外侵袭的影响,作者试图明确p38 MAPK信号通路在调节MMPs和金属蛋白酶组织抑制剂(TIMPs)中的作用,这些MMPs和TIMPs在人胶质母细胞瘤D54细胞系中被佛波酯(佛波醇-12-肉豆蔻酸酯-13-乙酸酯[PMA])激活。

方法

加入针对这些激酶的磷酸化特异性抗体后,使用蛋白质免疫印迹分析确定MAPKs的激活情况;使用明胶酶谱法和蛋白质免疫印迹分析来分析MMPs和TIMPs的状态;使用改良的Boyden小室法分析D54细胞和其他胶质瘤细胞的侵袭率。用PMA处理D54细胞可激活两种不同的MAPKs,即细胞外信号调节激酶(ERK)1/2和p38 MAPK,但不激活c-Jun氨基末端激酶/应激激活蛋白激酶。PMA诱导的MMP-9产生及MMP-2激活被p38 MAPK的特异性抑制剂SB203580阻断,但未被ERK 1/2的特异性抑制剂PD98059阻断。此外,在这些细胞中,SB203580逆转了PMA诱导的TIMP-1和TIMP-2分泌下调以及膜型I MMP(一种细胞表面MMP-2的主要激活剂)上调;当将SB203580添加到改良Boyden小室的上室时,PMA诱导的体外侵袭增加减少;并且该抑制剂还降低了各种胶质瘤细胞系中的MMP分泌及PMA诱导的体外侵袭。

结论

这些结果表明,PMA激活p38 MAPK在D54细胞中对MMPs和TIMPs的调节起核心作用,这对肿瘤侵袭和转移有重大影响。此外,SB203580抑制p38 MAPK可阻断MMPs的分泌及各种胶质瘤细胞的体外侵袭,突出了p38 MAPK抑制剂作为恶性胶质瘤抗侵袭和/或抗转移药物的可能作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验